PeptideDB

Pteridine-2,4(1H,3H)-dione 487-21-8

Pteridine-2,4(1H,3H)-dione 487-21-8

CAS No.: 487-21-8

Pteridine-2,4(1H,3H)-dione is an endogenously produced metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Pteridine-2,4(1H,3H)-dione is an endogenously produced metabolite.

Physicochemical Properties


Molecular Formula C6H4N4O2
Molecular Weight 164.12
Exact Mass 164.033
CAS # 487-21-8
PubChem CID 10250
Appearance Light yellow to brown solid powder
Density 1.8±0.1 g/cm3
Boiling Point 551.1±60.0 °C at 760 mmHg
Melting Point 300 °C
Flash Point 287.1±32.9 °C
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.809
LogP -1.26
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 0
Heavy Atom Count 12
Complexity 230
Defined Atom Stereocenter Count 0
InChi Key UYEUUXMDVNYCAM-UHFFFAOYSA-N
InChi Code

InChI=1S/C6H4N4O2/c11-5-3-4(8-2-1-7-3)9-6(12)10-5/h1-2H,(H2,8,9,10,11,12)
Chemical Name

1H-pteridine-2,4-dione
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation Lumazine is a 2,4-dihydroxypteridine.
Lumazine has been reported in Formica polyctena with data available.

Solubility Data


Solubility (In Vitro) DMSO: 50 mg/mL (304.66 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 3: 2.5 mg/mL (15.23 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 6.0931 mL 30.4655 mL 60.9310 mL
5 mM 1.2186 mL 6.0931 mL 12.1862 mL
10 mM 0.6093 mL 3.0466 mL 6.0931 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.